Terms: = Lung cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951
146 results:
1. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell lung cancer in Administrative Claims Databases.
Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
[TBL] [Abstract] [Full Text] [Related]
2. Surgical Outcomes in Non-Small Cell lung cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
Park S; Choe J; Lee SM; Choi S; Kim MJ; Chae EJ; Seo JB
Ann Surg Oncol; 2024 May; 31(5):3448-3458. PubMed ID: 38386197
[TBL] [Abstract] [Full Text] [Related]
3. [Construction of a Prognostic Prediction Model of Patients with Pathologic N0
in Resected Invasive Mucinous Adenocarcinoma of the lung].
Wang Z; He J; Shen H; Chen X; Lin C; Yu H; Gao J; He X; Shen W
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):47-55. PubMed ID: 38296625
[TBL] [Abstract] [Full Text] [Related]
4. Clinical characteristics and surgical outcomes of cardiac myxoma: A meta-analysis of worldwide experience.
Oktaviono YH; Saputra PBT; Arnindita JN; Afgriyuspita LS; Kurniawan RB; Pasahari D; Milla C; Wungu CDK; Susilo H; Multazam CECZ; Alkaff FF
Eur J Surg Oncol; 2024 Feb; 50(2):107940. PubMed ID: 38219702
[TBL] [Abstract] [Full Text] [Related]
5. Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into cancer and Nutrition.
Botteri E; Peveri G; Berstad P; Bagnardi V; Hoff G; Heath AK; Cross AJ; Vineis P; Dossus L; Johansson M; Freisling H; Matta K; Huybrechts I; Chen SLF; B Borch K; Sandanger TM; H Nøst T; Dahm CC; Antoniussen CS; Tin Tin S; Fournier A; Marques C; Artaud F; Sánchez MJ; Guevara M; Santiuste C; Agudo A; Bajracharya R; Katzke V; Ricceri F; Agnoli C; Bergmann MM; Schulze MB; Panico S; Masala G; Tjønneland A; Olsen A; Stocks T; Manjer J; Aizpurua-Atxega A; Weiderpass E; Riboli E; Gunter MJ; Ferrari P
Eur J Epidemiol; 2024 Feb; 39(2):147-159. PubMed ID: 38180593
[TBL] [Abstract] [Full Text] [Related]
6. [Relationship Between Dynamic Compliance and Airway Resistance and Infection Indicators in Elderly Patients With lung Infection After Radiotherapy for Esophageal cancer].
Tian Z; Tian W; Li H; Xue X; Zhao N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1245-1249. PubMed ID: 38162050
[TBL] [Abstract] [Full Text] [Related]
7. Explainable machine learning model based on clinical factors for predicting the disappearance of indeterminate pulmonary nodules.
Wang J; Sourlos N; Heuvelmans M; Prokop M; Vliegenthart R; van Ooijen P
Comput Biol Med; 2024 Feb; 169():107871. PubMed ID: 38154157
[TBL] [Abstract] [Full Text] [Related]
8. Risk Factors for Chronic Atrial Fibrillation Following lung Lobectomy.
Halloran SJ; Martin S; Jiang B; Bassiri A; Sinopoli J; Vargas LT; Linden PA; Towe CW
J Surg Res; 2024 Mar; 295():350-356. PubMed ID: 38064975
[TBL] [Abstract] [Full Text] [Related]
9. Prevalence and associations of poor mental health in the third year of COVID-19: U.S. population-based analysis from 2020 to 2022.
Kim J; Linos E; Rodriguez CI; Chen ML; Dove MS; Keegan TH
Psychiatry Res; 2023 Dec; 330():115622. PubMed ID: 38006717
[TBL] [Abstract] [Full Text] [Related]
10. Non-small cell lung cancer chemotherapy treatment outcomes and ethnicity: a twenty-year single-centre patterns of care study.
Nguyen H; Keenan R; Kennedy I; Lao C; Lawrenson R
N Z Med J; 2023 Nov; 136(1585):24-34. PubMed ID: 37956355
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Value of Nivolumab Clearance in Non-Small Cell lung cancer Patients for Survival Early in Treatment.
Otten LS; Piet B; van den Haak D; Schouten RD; Schuurbiers M; Badrising SK; Boerrigter E; Burgers SA; Ter Heine R; van den Heuvel MM
Clin Pharmacokinet; 2023 Dec; 62(12):1749-1754. PubMed ID: 37856040
[TBL] [Abstract] [Full Text] [Related]
12. Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score-matched NCDB Analysis.
Cantrell JN; Acharya P; Vesely SK; Gunter TC
Am J Clin Oncol; 2023 Nov; 46(11):503-511. PubMed ID: 37679872
[TBL] [Abstract] [Full Text] [Related]
13. Time intervals and previous primary care consultations in the pathway to emergency cancer diagnosis.
Bosch X; Montori-Palacin E; Calvo J; Carbonell I; Naval-Álvarez J; Moreno P; López-Soto A
Cancer Epidemiol; 2023 Oct; 86():102445. PubMed ID: 37651939
[TBL] [Abstract] [Full Text] [Related]
14. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
Ninomiya T; Ishikawa N; Kozuki T; Kuyama S; Inoue K; Yokoyama T; Kanaji N; Yasugi M; Shibayama T; Aoe K; Ochi N; Fujitaka K; Kodani M; Ueda Y; Watanabe K; Bessho A; Sugimoto K; Oze I; Hotta K; Kiura K
Lung Cancer; 2023 Oct; 184():107349. PubMed ID: 37651927
[TBL] [Abstract] [Full Text] [Related]
15. Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: Systematic review and network meta-analysis.
Luo Y; Zhang Z; Guo X; Tang X; Li S; Gong G; Gao S; Zhang Y; Lin S
Lung Cancer; 2023 Oct; 184():107319. PubMed ID: 37597303
[TBL] [Abstract] [Full Text] [Related]
16. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
17. Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.
Rupp M; Fanton-Aita F; Snow S; Wheatley-Price P; Melosky B; Juergens RA; Chu Q; Blais N; Banerji S; Ng R; Khoudigian S; Sharma A; On PV; Liu G
Curr Oncol; 2023 Jul; 30(7):6559-6574. PubMed ID: 37504341
[TBL] [Abstract] [Full Text] [Related]
18. AI Body Composition in lung cancer Screening: Added Value Beyond lung cancer Detection.
Xu K; Khan MS; Li TZ; Gao R; Terry JG; Huo Y; Lasko TA; Carr JJ; Maldonado F; Landman BA; Sandler KL
Radiology; 2023 Jul; 308(1):e222937. PubMed ID: 37489991
[TBL] [Abstract] [Full Text] [Related]
19. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study.
Hou F; Hou Y; Sun XD; Lv J; Jiang HM; Zhang M; Liu C; Deng ZY
PeerJ; 2023; 11():e15678. PubMed ID: 37456882
[TBL] [Abstract] [Full Text] [Related]
20. lung adenocarcinoma associated with cystic airspaces: Predictive value of CT features in assessing pathologic invasiveness.
Zhu H; Zhang L; Huang Z; Chen J; Sun L; Chen Y; Huang G; Chen Q; Yu H
Eur J Radiol; 2023 Aug; 165():110947. PubMed ID: 37392546
[TBL] [Abstract] [Full Text] [Related]
[Next]
